InvestorsHub Logo
Followers 8
Posts 3492
Boards Moderated 0
Alias Born 10/09/2019

Re: None

Wednesday, 08/12/2020 1:37:57 AM

Wednesday, August 12, 2020 1:37:57 AM

Post# of 7354
Jos Schmitt of the NEO Exchange is all in on the medical benefits of psychedelic drugs.

“We need to get over that stigma,” said Schmitt, who is president and CEO of the NEO, about the initial doubts that psychedelics as an investment proposition will face.

In an exclusive interview with the Investing News Network (INN), the executive spoke at length about the potential of psychedelics and why the opportunity should entice investors.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y